Top Markets
Coin of the day
Palvella Therapeutics, Inc. Palvella Therapeutics, Inc.

Palvella Therapeutics, Inc.

PVLA
Classifica tra le azioni #6151
Palvella Therapeutics, Inc. is a clinical-stage biopharmaceutical company... Palvella Therapeutics, Inc. is a clinical-stage biopharmaceutical company dedicated to the discovery, development, and commercialization of innovative treatments for patients afflicted with severe and uncommon inherited skin conditions. Central to its pipeline is QTORIN 3.9% rapamycin anhydrous gel (referred to as QTORIN rapamycin), which is currently undergoing Phase 3 clinical trials for microcystic lymphatic malformations. Additionally, this drug is in Phase 2 evaluation for treating cutaneous venous malformations. Beyond these specific indications, Palvella is also advancing QTORIN rapamycin for the treatment of other dermatological diseases driven by the mTOR pathway. The company's headquarters are situated in Wayne, Pennsylvania.
Prezzo delle azioni
$153.93
Capitalizzazione di mercato
$2.21B
Variazione (1 giorno)
-0.26%
Variazione (1 anno)
172.68%
Paese
US
Scambia Palvella Therapeutics, Inc. (PVLA)

Categoria

Storico del prezzo dell'azione per Palvella Therapeutics, Inc. (PVLA)
Prezzo di chiusura più alto: $151.68 il 2026-08-01

Prezzo di chiusura più basso: $13.11 il 2024-12-01
Storico del prezzo dell'azione di Palvella Therapeutics, Inc. dal 2024 al 2026
Andamento annuale del prezzo dell'azione
Anno Performance
2026 (TTM) 7.48%
2025 649.84%
2024 0.00%
Prezzo dell'azione per aziende simili o concorrenti
Azienda Prezzo dell'azione Variazione 1a% Il paese
$547.47 40.71%
US
$1.05K 49.01%
NL
$122.63 -12.65%
AU
$138.95 453.59%
US
$765.25 7.19%
CH